The patent covers for delivering shock waves into living tissue through a multi-adjustable reflector contained within a tissue-contacting treatment applicator.

The applicator allows in adjusting the positions where shock waves are generated and delivers it into the body to produce compressive and tensile stresses on cells and tissue structures which are designed to promote angiogenic and positive inflammatory responses, and quickly initiate the healing cascade.

The patent also provides the improvement of a fastening or ‘pivot’ point within the applicator’s housing to enable the reflector to tilt in any direction, thus increasing the volume of tissue treated from a single applicator position.

Sanuwave president and CEO Christopher Cashman said this patent protects the capability of their proprietary technology and has the potential to expand treatment options, including the ability to target a wider variety of tissues in the pursuit of new clinical applications.